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Mesotelencephalic pathways in the adult central nervous system have been studied
in great detail because of their implication in major physiological functions as well as
in psychiatric, neurological, and neurodegenerative diseases. However, the ontogeny of
these pathways and the molecular mechanisms that guide dopaminergic axons during
embryogenesis have been only recently studied. This line of research is of crucial interest
for the repair of lesioned circuits in adulthood following neurodegenerative diseases or
common traumatic injuries. For instance, in the adult, the anatomic and functional repair
of the nigrostriatal pathway following dopaminergic embryonic neuron transplantation
suggests that specific guidance cues exist which govern embryonic fibers outgrowth,
and suggests that axons from transplanted embryonic cells are able to respond to
theses cues, which then guide them to their final targets. In this review, we first
synthesize the work that has been performed in the last few years on developing
mesotelencephalic pathways, and summarize the current knowledge on the identity of
cellular and molecular signals thought to be involved in establishing mesotelencephalic
dopaminergic neuronal connectivity during embryogenesis in the central nervous system
of rodents. Then, we review the modulation of expression of these molecular signals in the
lesioned adult brain and discuss their potential role in remodeling the mesotelencephalic
dopaminergic circuitry, with a particular focus on Parkinson’s disease (PD). Identifying
guidance molecules involved in the connection of grafted cells may be useful for cellular
therapy in Parkinsonian patients, as these molecules may help direct axons from grafted
cells along the long distance they have to travel from the substantia nigra to the striatum.
Keywords: mesotelencephalic pathway, development, axon guidance, dopamine, Parkinson’s disease,
transplantation
INTRODUCTION
Mesencephalic dopaminergic (mDA) neurons are located in the
retrorubral field (RRF; A8 neurons), substantia nigra pars com-
pacta (SNc; A9 neurons), and ventral tegmental area (VTA;
A10 neurons) and give rise to ascending axonal projections
in the telencephalon. These so-called mesotelencephalic pro-
jections are organized into three main pathways: the mesos-
triatal, mesocortical, and mesolimbic pathways. Axons arising
from the VTA and the dorsal part of the SNc and the RRF
project to (1) the anteromedial and ventral parts of the stria-
tum (including the nucleus accumbens) and the central nucleus
of the amygdala, and (2) the cortex, where they give rise to
the mesolimbic and mesocortical pathways. The dorsal and ven-
tral tiers of the SNc and RRF contain dopaminergic neurons
that project axons mainly to the dorsolateral (sensorimotor)
striatum, and form the mesostriatal pathway or the nigrostri-
atal pathway, in a restricted sense (Bjorklund and Dunnett,
2007). The latter plays a critical role in the initiation of move-
ment. In humans, the specific loss of SNc dopaminergic neurons
is a pathological hallmark of the development and progres-
sion of Parkinson’s disease (PD). Indeed, dopaminergic cells
located in the SNc degenerate, which results in an impaired
motor control associated with a dopamine deficit in the stria-
tum. The reasons that this degeneration occurs are not yet fully
understood. However, polymorphisms detected in genes coding
for axon-guidance molecules are thought to contribute to the
pathogenesis of PD, through miswiring of the mesotelencephalic
pathway during development, thus increasing the risk of PD
(Lesnick et al., 2007). Cell replacement therapy has been investi-
gated in an animal model of PD as a possible means to replace
dopaminergic neurons that have been lost. This strategy con-
sists of grafting embryonic dopaminergic neurons in most cases
in the striatum, or, less often, in the site of lesion (i.e., in the
SN) (Lindvall and Björklund, 2004, 2011; Gaillard and Jaber,
2011). A major challenge in transplant therapies in the SN is to
determine to what extent axons of grafted dopaminergic neu-
rons will be able to grow along appropriate pathways to reach
their targets. Gaillard et al. (2009) and Thompson et al. (2009)
showed that embryonic cells grafted in the lesioned SN of mice
resulted in the repair of the lesioned pathway, both anatomi-
cally and functionally. These results suggest that guidance cues
that specifically govern embryonic fibers outgrowth exist in the
adult brain, and that transplanted embryonic cells are able to
respond to these cues, which guide them to their final tar-
get. Understanding how dopaminergic axons navigate through
their native environment during development may contribute to
increasing efficiency of cell therapy for brain diseases. Although
the ontogeny of the mesostriatal pathway has been investigated
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for the past 20 years, interesting new data have recently emerged,
that we summarize here.
ESTABLISHMENT OF THE MESOTELECENCEPHALIC
PATHWAY DURING EMBRYOGENESIS
Sonic hedgehog (Shh) signaling triggers the development of
dopaminergic neurons from E10 onwards from the ventral mid-
line region (Hynes et al., 1995; Blaess et al., 2006) of the ventric-
ular zone of the rhombencephalic isthmus. These neurons then
migrate along the radial glia up to the ventral mesencephalon
(VM) (Altman and Bayer, 1981; Specht et al., 1981a,b; Marchand
and Poirier, 1983; Smidt and Burbach, 2007; Tang et al., 2009).
Proper Wingless-type (Wnt) signaling is required for the cor-
rect cell body orientation of mDA neurons, which is disrupted in
mice mutant for the planar cell polarity (PCP) receptor Frizzled3
(Fenstermaker et al., 2010). mDA neurons are immunoreactive
for tyrosine hydroxylase (TH) at E12 (Specht et al., 1981a,b) and
for dopamine at E14 (Voorn et al., 1988). From E11.5 onwards,
mDA neurons extend their axons along the dorsoventral and the
anteroposterior axis to reach their telencephalic targets. During
this long path to the rostral part of the brain, directed mDA
axon growth is dependent on regional specification and pattern-
ing within the mesencephalon, diencephalon, and telencephalon.
Three main steps are then crucial for axon guidance duringmouse
embryogenesis. First, from E11.5 to E13.5, the axons ofmDA neu-
rons of the mesencephalon extend dorsally from the ventrocaudal
region of the midbrain, and then turn rostrally. Second, at E13.5,
these axons navigate longitudinally through the midbrain and the
diencephalon to form the medial forebrain bundle (MFB). Third,
from E14.5 to E18.5, they reach the telencephalon, and more par-
ticularly the region of the forebrain that gives rise to the striatum,
and innervate the limbic system and the neocortex (Specht et al.,
1981a,b; Voorn et al., 1988).
AXON GUIDANCE IN THE MESENCEPHALON
After localizing in the VM at E11.5, mDA neurons start their
axonal growth dorsally and rostrally, away from the caudal and
dorsal mesencephalon (CM and DM) (Figure 1). Nakamura et al.
FIGURE 1 | Mesencephalic guidance: expression of repulsive (in red) and
attractive (in blue) guidance cues in the environment of mDA somas and
axons between E11.5 and E13.5 in mice. mDA axons (in green) navigate in
a ventrorostral direction. The expression of guidance molecule receptors in
these cells is reported: receptors expressed in all or most of the midbrain
TH-expressing cells (TH+) are underlined, whereas receptors expressed in a
small fraction of TH-expressing neurons are not. The expression of these
receptors has been determined either at the mRNA or the protein level, for
one or several stages of development between E11.5 and E13.5 (see details
in the text). FGF8 has an indirect repulsive action on mDA axons through the
activation of Sema3F expression. The cephalic vesicles telencephalon,
diencephalon, mesencephalon, and rhombencephalon are delimited in
yellow, beige, pink, and purple, respectively. Aq, aqueduct; CM, caudal
mesencephalon; DM, dorsal mesencephalon; DT, dorsal thalamus; Hypothal,
hypothalamus; LV, lateral ventricle; MGE, medial ganglionic eminence; MHB,
midbrain-hindbrain boundary; sc, superior colliculus; VM, ventral
mesencephalon; VT, ventral thalamus; 3V, third ventricle; 4V, fourth ventricle.
1Yamauchi et al., 2009; 2Hernandez-Montiel et al., 2008; 3Kolk et al., 2009;
4Torre et al., 2010; 5Vitalis et al., 2000; 6Lin et al., 2005; 7Marillat et al., 2002;
8Fenstermaker et al., 2010; 9Blakely et al., 2011.
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(2000), and then Gates et al. (2004), supported the notion that
short-range cues in the midbrain directed the mDA axons ros-
trally. At the time, the guidance cues involved could not be iden-
tified, but the authors showed that removing the diencephalon or
the isthmus did not affect the rostrally directed growth of mDA
axons. They concluded that the rostral orientation of the mDA
fibers was not due to the action of diffusible molecules secreted
by the diencephalon. Moreover, considering that mDA neu-
rons localize near the midbrain-hindbrain boundary (MHB), the
authors suggested that molecules under the control of the orga-
nizing activity of the isthmus, such as ephrin-A2 and ephrin-A5,
could control the polarity of axon growth along the rostrocaudal
axis through their repulsive activity.
Later, Yamauchi et al. (2009) showed that a signaling cen-
ter located at the MHB regulates the rostrally directed growth
of mDA axons in rats during early development (at E10–E13).
They reported that beads soaked with fibroblast growth factor 8
(FGF8), a signaling molecule that mediates the patterning activ-
ities of the MHB, repel mDA axons that extend through the
diencephalon. The authors suggested that this repulsion could
be mediated by semaphorin 3F (Sema3F) because (1) FGF8-
soaked beads induced an increase in the expression of Sema3F,
(2) Sema3F expression in the midbrain was abolished by a tyro-
sine kinase inhibitor of an FGF receptor, and (3) mDA axonal
growth was inhibited by Sema3F. Furthermore, mDA axons
expressed a Sema3F receptor, neuropilin-2 (Npn-2), and the
removal of Npn-2 by gene targeting resulted in the aberrant cau-
dal growth of mDA axons. Thus, these results indicate that the
MHB signaling center could regulate the growth polarity of mDA
axons along the rostrocaudal axis by inducing Sema3F activity.
Similarly, the rostrocaudal gradient of Sema3F in the VM may
contribute to the rostral orientation of mDA axons by repuls-
ing them rostrally, as suggested by Kolk et al. (2009). Sema3F
and Sema3C, which are also expressed in the pretectum, induce
a repulsive and an attractive effect on mDA axons, respectively.
The pretectal attraction is partially dependent on the interac-
tion with Npn-1 and Npn-2, both expressed in a subset of mDA
axons and somas (Hernandez-Montiel et al., 2008). Moreover,
Sema3A is detected at E13.5 in the rat VM, and the expression of
its receptors and co-receptors Npn-1, Npn-2, plexin-A1, plexin-
A3, L1CAM, and NrCAM (Torre et al., 2010) in mDA neurons
may also induce, by repulsion, the guidance of mDA axons. More
precisely, Sema3A receptors and co-receptors are differentially
expressed in mDA cells. Indeed, Npn-1, L1CAM, and plexin-
A1 are weakly expressed in a small fraction of TH-expressing
neurons in the VM, whereas Npn-1 is strongly expressed in a
large number of non-dopaminergic neurons. Npn-2, NrCAM,
and plexin-A3 are found in both neurons expressing TH and
not expressing TH, and plexin-A3 is more particularly found in
a large fraction of TH-expressing neurons (Torre et al., 2010).
Plexin-A1 is found in a low number of TH-positive axons in
the MFB (Torre et al., 2010), whereas Npn-2 is found on a sub-
set of mDA axons at E13.5 in the rat (Yamauchi et al., 2009).
Thus, it is important to consider that different subpopulations of
mDA neurons could differentially respond to their environment.
Other diffusible guidance molecules expressed in the VM, such as
netrin-1, participate in the ventral orientation of mDA axons that
express the DCC receptor in rat embryos at E14 (Lin et al., 2005),
in a chemorepellent and/or chemoattractive manner (Vitalis et al.,
2000).
In addition, Robo1 and Robo2 mRNAs and proteins are dif-
ferentially expressed during rat embryonic development (from
E15 to E20) in the SN and in the VTA. The Robo1 protein is
expressed in both calbindin- and Girk2-expressing cells in the
VM of rat embryos at E14, while the Robo2 protein is exclu-
sively found in the calbindin-expressing subpopulation (Lin et al.,
2005). This suggests a differential guidance between the two sub-
populations of mDA neurons. A repulsive interaction between
Robo1 and Robo2 receptors expressed by mDA neurons and
their ligands (Slit-1 and Slit-3) present in the DM and CM con-
tributes to the rostrocaudal reorientation of mDA axons (Marillat
et al., 2002; Lin et al., 2005). Fenstermaker et al. (2010) recently
revealed the role of Wnt and PCP receptor proteins in the antero-
posterior guidance of mDA axon projections. Frizzled3, Celsr3,
and Vangl2 PCP receptors are widely expressed in the midbrain
region and in all TH-expressing mDA neurons, as shown by co-
immunostaining against PCP proteins and TH between E11.5
and E14.5 in mouse embryos (Fenstermaker et al., 2010). In
addition, Wnt5a is expressed in a high posterior/low anterior
gradient, whereas Wnt7b is expressed in a high anterior/low pos-
terior gradient in the midbrain. Wnt5a promotes the retraction
and repulsion of mDA axons partly through Frizzled receptors,
as shown by in vitro functional assays (Blakely et al., 2011),
whereas Wnt7b has an attractive effect. In PCP signaling mutants,
mDA axons are severely misguided along the anteroposterior axis.
Indeed, instead of being rostrally oriented, as shown in wild-type
mice, mDA axons of Frizzled3, Celsr3, and Vangl2 (Lp/Lp) mutant
mice display aberrant dorsal and caudal projections (from E12.5
until E17.5).
AXON GUIDANCE IN THE DIENCEPHALON
Once the rostrally oriented growth begins at E13.5, mDA axons
become highly restricted to a narrow path. This narrow path
appears to result from multiple signals that keep axons from
diverging ventrally or dorsally (Figure 2).
In 1992, the presence of adhesive molecules was proposed to
explain the fasciculation of mDA neurons in the MFB (Shults
et al., 1992). Indeed, the nerve growth factor-inducible large
external (NILE) protein is mostly present between E13 and E20,
in fasciculated mDA axons coursing rostrally from the mesen-
cephalon. The authors hypothesized that NILE found on the
surface of pioneer axons could define a pathway with adhesive
cues for these axons, as it had been shown for L1/NgCAM, which
promotes the elongation of axons from embryonic mDA neurons
in vitro (Shults et al., 1992).
Since then, several other diffusible guidance molecules playing
a role in maintaining the MFB fasciculation have been described.
Indeed, Sema3F expressed in the VM may participate to tighten
this tract via its repulsive interaction with Npn-2 expressed by
mDA neurons (Kolk et al., 2009; Torre et al., 2010). Similarly,
the repulsive interaction between Sema3A, expressed in the mid-
line, and its receptors Npn-1, Npn-2, plexin-A1, and plexin-A3,
expressed by mDA neurons, could help maintain these fibers in
an ipsilateral trajectory (Kawano et al., 2003; Torre et al., 2010).
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FIGURE 2 | Diencephalic guidance: expression of repulsive (in red) and
attractive (in blue) guidance cues in the environment of mDA somas and
axons at E13.5 in mice. mDA axons (in green) fasciculate in a ventrorostral
direction to form the MFB. mDA axons respond to environmental cues
through specific receptors (in green). Receptors expressed in all or most of
the midbrain TH-expressing cells (TH+) are underlined, whereas receptors
expressed in a small fraction of TH-expressing neurons are not. The
expression of these receptors has been determined either at the mRNA or
the protein level around E13.5 (see details in the text). Nkx2.1 has an
indirect repulsive action on mDA axons through the activation of Slit-2
expression. Pax6 allows the mDA fibers to navigate ventrally through the
expression of a repulsive action of netrin-1. The cephalic vesicles
telencephalon, diencephalon, mesencephalon, and rhombencephalon are
delimited in yellow, beige, pink, and purple, respectively. Aq, aqueduct;
Hypothal, hypothalamus; LGE, lateral ganglionic eminence; LV, lateral
ventricle; MFB, medial forebrain bundle; MGE, medial ganglionic
eminence; RM, rostral mesencephalon; sc, superior colliculus; Thal,
thalamus; VM, ventral mesencephalon; 4V, fourth ventricle. 1Deschamps
et al., 2009; 2 Marín et al., 2002; 3Kolk et al., 2009; 4Torre et al., 2010; 5Vitalis
et al., 2000; 6Lin et al., 2005; 7Dugan et al., 2011; 8Kawano et al., 2003;
9Blakely et al., 2011; 10Xu et al., 2010; 11Hammond et al., 2009; 12Deschamps
et al., 2010.
Double immunostaining in rat embryos at E13.5 and in
VM cultures showed that Npn-2, NrCAM, and plexin-A3 are
expressed in a large subset of TH-expressing neurons (Kolk
et al., 2009; Torre et al., 2010), whereas single immunostaining
for Npn-1 showed that the MFB fibers are faintly immunore-
active for this receptor in mouse embryos at E12.5 (Kawano
et al., 2003). This suggests that Sema3A may principally acts on
mDA axons through its interaction with Npn-2, NrCAM, and
plexin-A3.
The presence of diffusible repulsive molecules, such as Slit-
1 and Slit-2, in the midline of mouse embryos at E13.5 (Bagri
et al., 2002; Marín et al., 2002) prevents MFB fibers from crossing
via their interactions with Robo1 and Robo2 expressed in sub-
populations of mDA neurons (Lin et al., 2005). Indeed, mDA
fibers in the MFB of Slit-2 mutants are ventrally displaced as
they course through the diencephalon. In Slit-1-Slit-2 double
mutants, the MFB is split into two components and numerous
fibers descend ventrally into the hypothalamus, toward the mid-
line (Bagri et al., 2002). Dugan et al. (2011) confirmed that the
Slit proteins contribute to guiding the mDA projections through
the diencephalon. Indeed, mDA axons make significant pathfind-
ing errors in Slit-1/2 and Robo1/2 double knockout mice, such
as spreading out in the diencephalon to form a wider tract. The
wider tract results from a combination of the invasion of the ven-
tral midline, consistent with Slit repulsion, and a dorsal expansion
of axons, away from the ventral midline. Aberrant dorsal tra-
jectories are prominent in Robo1 and Robo1/2 knockout mice,
suggesting that Robo proteins may promote mDA axon fascicula-
tion into tightly organized tracts, independently of Slit proteins.
Moreover, mDA axons are not pioneers, but project into an envi-
ronment where they likely interact and possibly fasciculate with
pre-existing tracts. As earlier tracts may also be dependent on
Slit/Robo guidance (Marion et al., 2005; Tsuchiya et al., 2009),
mDA projections errors may be a secondary consequence of the
earlier tract errors.
Short-range cues may also participate in maintaining the
MFB fasciculation. Indeed, ephrin-A5 expression in the thala-
mus (Deschamps et al., 2009, 2010) may maintain mDA fibers
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in a ventral position, on one hand, through its repulsive inter-
action with EphA5 expressed in the mDA neurons (Deschamps
et al., 2009), and on the other hand, via its positive action on axon
growth (Cooper et al., 2009). Indeed, it has been shown in vitro
that neurons originating from the VM grow on thalamic explants
without being connected to it (Gates et al., 2004).
Marín et al.’s (2002) studies on Nkx2.1 mutant mice revealed
the importance of ephrin, semaphorin and Slit molecules for
mDA axon guidance. Indeed, these authors found that mDA
fibers abnormally converge toward the rostral midline in the
diencephalon (hypothalamus) in the absence of Nkx2.1. In this
mutant, the expression of ephrin-A5, EphB2, EphB3, Sema3C,
and Slit-2 is downregulated, whereas the expression of Sema3A,
Sema3F, and Slit-1 is upregulated. Slit-2 expression is absent from
the hypothalamus, where it normally contributes to repel mDA
fibers from the midline.
In addition, Shh, which is expressed in the ventral-medial mid-
brain and hypothalamus during mDA axonal outgrowth, acts as a
local guidance cue for medially projecting mDA axons. Indeed, in
midbrain explants, dopaminergic projections are attracted to an
Shh source. In addition, the most medial dopaminergic projec-
tions are deficient when Shh signaling is inactivated during late
neuronal development in mice (Hammond et al., 2009). These
results suggest that medial and lateral mDA neuron populations
have a differential sensitivity to Shh chemoattraction.
Although mDA neurons do not express Pax6 at E13.5 (Vitalis
et al., 2000), mice lacking Pax6 display an altered pathfinding
of mDA projections. Thus, instead of following the route of the
MFB ventrally, most of the mDA axons are deflected dorsoros-
trally at the pretectal-dorsal thalamic transition zone and in the
dorsal thalamic alar plate, migrating away from the abnormally
expanded netrin-1 expression. Moreover, Xu et al. (2010) detected
an aberrant dopaminergic ventral commissure descending from
the MFB and crossing the midline at the level of the hypothala-
mus in DCC mutant mice. These data suggest that netrin-1 has
a chemorepellent activity on the pathfinding of mDA neurons
mediated by the DCC receptor, which is expressed in a large num-
ber of TH-expressing cells, as shown by immunohistochemistry
in mouse embryos at E14 (Xu et al., 2010).
More recently, Blakely et al. (2011) showed thatWnt5a mutant
mice display an abnormal fasciculation ofmDAaxons in theMFB.
Wnt5a is normally expressed in the vicinity of the mesostriatal
pathway during development and acts as a chemorepellent for
mDA neurites as shown in VM explants in vitro.
AXON GUIDANCE IN THE TELENCEPHALON
After their navigation in the MFB, mDA projections invade the
striatum in a ventrodorsal direction between E14.5 and birth
(Figure 3). A high rostral and ventral ephrin-A5 expression was
detected in the striatum (Deschamps et al., 2009), suggesting
FIGURE 3 | Telencephalic guidance: expression of repulsive (in red) and
attractive (in blue) guidance cues in the environment of mDA somas and
axons between E14.5 and E18.5 in mice. mDA axons (in green) connect to
the telencephalic regions through specific receptors (in green).
The expression of these receptors has been detected in the mDA cells in the
VM using double immunostaining against TH and protein receptors.
Receptors expressed in all or most of the midbrain TH-expressing (TH+) cells
are underlined, whereas receptors expressed in a small fraction of
TH-expressing cells are not. EphB1 has been detected at the mRNA level in
the VM. The repulsive effect of Sema7A on mDA axons remains to be
determined5 . The cephalic vesicles telencephalon, diencephalon,
mesencephalon, and rhombencephalon are delimited in yellow, beige, pink,
and purple, respectively. Cx, cortex; LGE, lateral ganglionic eminence; SN,
substantia nigra; OT, olfactory tract; PFC, prefrontal cortex; sc, superior
colliculus; Thal, thalamus; VTA, ventral tegmental area. 1Deschamps et al.,
2009; 2Hernandez-Montiel et al., 2008; 3Janis et al., 1999; 4Yue et al., 1999;
5Pasterkamp et al., 2007; 6Lin et al., 2005; 7Marillat et al., 2002;
8Fenstermaker et al., 2010; 9Hamasaki et al., 2001; 10Xu et al., 2010.
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that ephrin-A5 may repel mDA projections (as shown in vitro)
toward the domainswith low dorsal and caudal ephrin-A5 expres-
sion. This ephrin-A5 expression gradient may help the mDA
axons to spread within the striatum: low-responding ephrin-
A5 mDA axons may be preferentially connected in the ventral
part of the striatum, whereas high-responding ephrin-A5 mDA
axons may be repelled toward the dorsal part of the striatum.
Moreover, in the most ventral part of the telencephalon, mDA
axons not responding to ephrin-A5 may grow to connect corti-
cal regions. This neural map specification through gradients is a
well-known mechanism used by ephrins. Ephrins regulate axon
growth allowing axons to terminate at a neutral or optimum
point in the gradient, as extensively shown for the retinotectal
and thalamocortical systems (Flanagan, 2006). This mechanism
could explain the graded distribution of dopaminergic projec-
tions in the striatum during development and the extinction of
ephrin-A5 expression when mDA axons connect to the entire
striatum at P7. Moreover, this model was supported by the work
of Sieber et al. (2004), who showed that the disruption of EphA-
ephrin-A interactions resulted in the mistargeting of a fraction
of SN dopaminergic projections, leading to a reduced number
of dopaminergic projections in the dorsolateral striatum. Indeed,
according to this model, a lack of ephrin-A–EphA signaling may
induce fewer dopaminergic projections connecting to the dorsal
part of the striatum, since they would not be repelled from the
ventral part. These axons would grow more ventrally instead of
turning dorsally into the striatum, and would then be misrouted
in the absence of ephrin-A–EphA signaling.
Other ephrins/Ephs may also be implicated in the estab-
lishment of these mesostriatal connections, such as EphB1, the
mRNA of which is differentially expressed in the VM (Yue et al.,
1999). Indeed, EphB1 is more intensively expressed in dopamin-
ergic neurons of the SNc than in dopaminergic neurons of the
VTA region in newborn mice. Its repulsive interaction with
ephrin-B2 strongly expressed in the ventral striatum may con-
tribute to the navigation of the nigrostriatal fibers toward the
dorsal part of the striatum (Yue et al., 1999; Hu et al., 2004). Later
in the postnatal development, dopamine activity has been shown
to regulate the developmental expression of EphB1 (Halladay
et al., 2000). Finally, the presence of ephrin-A2, -A3, and -A5,
differentially expressed in the striatal compartments, matrix and
striosome, suggests their implication in the formation and stabi-
lization of mesostriatal connections (Janis et al., 1999).
In addition, Marillat et al. (2002) suggested that mDA axons
could be guided through a Robo-Slit interaction toward their
telencephalic targets. Indeed, they showed that rat embryonic
mDA cells from the SNc express Robo1 and Robo2 mRNAs,
and that VTA dopaminergic cells mainly express Robo1 mRNA.
In the telencephalon, Slit-1 mRNA is expressed in the caudate
putamen, whereas Slit-1 and Slit-2 mRNAs are expressed in the
septum. Bagri et al. (2002) studied the distribution of mDA
fibers in Slit mutant mice. Although many dopaminergic fibers
entered the telencephalon normally in Slit-1-Slit-2 mutants, a
significant percentage abnormally crossed the midline in the
basal telencephalon. These defects were readily apparent at E14.5,
suggesting that loss of Slit function affects the development of
dopaminergic systems as they course rostrally into the forebrain.
Slit-1 and Slit-2 prevent the growth of dopaminergic axons into
ventral domains of the forebrain. In addition, Slit-1 inhibits the
axon growth of midbrain dopaminergic neurons in vitro (Lin
et al., 2005).
At E15.5 in the rat, Pasterkamp et al. (2007) showed that
neurons in the central part of the VTA express the plexin-C1
receptor and showed that its ligand Sema7A is detected in a
subset of SNc neurons, as well as in the striatum and the cor-
tex. This suggests that the interaction between plexin-C1 and
Sema7A contributes to the navigation of mDA axons to the telen-
cephalon. Other semaphorin receptors, such as Npn-1, Npn-2,
plexin-A1, and plexin-A3, are also expressed in mDA neurons
(Hernandez-Montiel et al., 2008; Torre et al., 2010). Npn-1 and
Npn-2 aremore particularly present in a fraction ofmDAneurons
and in mDA axons connecting pretectum explants in midbrain-
pretectum co-cultures (Hernandez-Montiel et al., 2008). From
a functional perspective, the interaction between Sema3F and
Npn-2mediates a chemoattraction that is required to orient mDA
axon projections to the cortical plate of the medial prefrontal cor-
tex (Kolk et al., 2009). When expressed in HEK293 cell aggregates,
Sema3A enhances axon growth. In addition, co-culture explants
from the striatum and the VM show an attractive effect on mDA
neurons. Attraction by the striatum is not affected by the pres-
ence of anti-Npn-1 antibodies (Hernandez-Montiel et al., 2008).
Overall, these studies support a role for semaphorin signaling in
dopaminergic axon pathfinding.
The attractive interaction between netrin-1 and DCCmay also
play a role in the mDA axon guidance to the striatum and the
cortex, through the expression of netrin-1 in these target regions
and the expression of DCC in mDA neurons (Hamasaki et al.,
2001; Xu et al., 2010). Moreover, UNC5, a netrin-1 receptor,
is also expressed in mDA neurons of rat embryos at E18 (Xu
et al., 2010). Interestingly, the DCC/UNC5 ratio in mDA neurons
varies during development, thus modulating the response of these
neurons to netrin-1, and consequently modifying the organiza-
tion and function of mesocorticolimbic dopaminergic systems
(Manitt et al., 2010).
Finally, the marked defects in mDA axon projections found
in the telencephalon of mutant mice for the PCP components
Frizzled3 and Celsr3 support the idea that Wnt signaling may
control anteroposterior guidance in the forebrain. Fenstermaker
et al. (2010) showed that, in the telencephalon, mDA axons of
Frizzled mutant mice are displaced ventrally and are located in
close vicinity to the optic chiasm. No innervation of synaptic tar-
get regions, such as the striatum or medial prefrontal cortex, by
mDA axons is found at E14.5 or E17.5. In Celsr3 mutant mice,
many mDA axons follow aberrant lateral, dorsal, and ventral tra-
jectories, and in contrast to Frizzled mutantmice, a small subset of
mDA axons reaches, but does not innervate, the striatum at E17.5
(Fenstermaker et al., 2010). Celsr3 is a protocadherin known to
be critical for the development of several major axonal bundles in
the CNS (Tissir et al., 2005). Thus, Wnt/PCP signaling may be an
anteroposterior guidancemechanism that controls the axonal and
cellular organization of this mesotelencephalic pathway. However,
Wnt5a does not seem to be the main actor involved, as mDA
axon projections in Wnt5a mutant mice only display a minor
and transient posterior projection, suggesting that the lack of
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Wnt5a signaling is compensated by other Wnt proteins in late
development stages (Fenstermaker et al., 2010).
AXONAL GUIDANCE CUES IN THE ADULT
MESOTELENCEPHALIC PATHWAYS
IN THE INTACT ADULT BRAIN
In the intact adult brain, the expression of axonal guidance cues
is globally downregulated with a persistent expression confined
to regions of high-plasticity (Yamaguchi and Pasquale, 2004).
Depending on the nature of the molecules considered, the local-
ization of their expression is either conserved throughout the
embryonic, postnatal, and adult life or may totally differ between
the embryonic and adult brains.
For instance, short-range cues, such as ephrins, are present
at low levels in the adult nigrostriatal system (Goldshmit et al.,
2006). Their function is to maintain the neuronal connections
and synaptic plasticity (Goldshmit et al., 2006). Ephrin-B2 is
expressed in the SN and the VTA, in the amygdala, hypotha-
lamus and, to a lesser extent, in the caudate putamen (Migani
et al., 2007). Several Eph receptors are also detected in the adult
brain, such as EphA4 in the nucleus accumbens, the hippocam-
pus and the thalamus (Xiao et al., 2006), as well as in the SN
and the cortex (Martone et al., 1997; Xiao et al., 2006). EphA5
is expressed in the VTA, the SN, the thalamus, the striatum, and
the cortex (Olivieri and Miescher, 1999; Cooper et al., 2009). The
constitutive expression of the dominant negative EphA5 recep-
tor containing a disrupted tyrosine kinase domain in the mouse
hippocampus and striatum results in altered striatal function-
ing, and more particularly, in spatial navigation accompanied
by a decrease in striatal dopamine (Yue et al., 2002; Halladay
et al., 2004). EphB1 is expressed in the nucleus accumbens,
in the thalamus and in the matrix compartments of the stria-
tum (Martone et al., 1997; Xiao et al., 2006), whereas EphB2 is
strongly expressed in the cortex (Moreno-Flores and Wandosell,
1999).
Some long-range cues are also present in the adult brain,
such as the DCC-netrin family, and their expression appears
to be similar to that of the developing brain. Indeed, DCC
immunoreactivity has been detected in A9 dopaminergic neu-
rons in the SN, and in A10 dopaminergic neurons predominantly
located in and around the interfascicular nucleus. Terminal fields
selectively labeled with DCC antibodies correspond to known
nigrostriatal projections to the dorsolateral striatal patches and
dorsomedial shell of the accumbens. The DCC immunoreac-
tivity is also detected in the prefrontal cortex, the septum, the
lateral habenula, and the ventral pallidum. This unique distribu-
tion of DCC immunoreactivity in adult mDA neurons suggests
that netrin-1/DCC signaling could contribute to the plasticity
and remodeling of dopaminergic projection pathways (Osborne
et al., 2005). Indeed, changes in netrin-1 receptor expression,
through the modulation of cAMP levels (Jassen et al., 2006), may
play a role in the lasting effects of exposure to amphetamine
and other stimulant drugs (Yetnikoff et al., 2007), and may con-
tribute to cognitive deficits associated with drug abuse (Bahi
and Dreyer, 2005). Netrin-1’s involvement in the rodent meso-
corticolimbic dopaminergic system has been recently confirmed
by Flores (2011), who described an upregulation of netrin-1
receptors by repeated exposure to stimulant drugs of abuse in
dopaminergic somatodendritic regions and a role for netrin-1 in
drug-induced behavioral plasticity. Moreover,Manitt et al. (2011)
revealed the implication of DCC-mediated netrin-1 signaling
in the establishment of medial prefrontal cortex dopaminergic
circuitry.
The distribution of secreted semaphorins has been extensively
studied in the postnatal and adult hippocampus of rodents. These
studies indicate that the expression of transcripts for specific
secreted semaphorins and neuropilins persists in a variety of
mature neurons (Hirsch et al., 1999; Miyasaki et al., 1999; Giger
et al., 2000; Holtmaat et al., 2002; Bagri et al., 2003; Barnes et al.,
2003). Their localization indicates that they are likely to func-
tion at the level of synapses (Mann et al., 2007). Thus, Sema3A
could modulate the morphology and the function of synapses in
the adult hippocampus (Bouzioukh et al., 2006). More recently, a
study on a putative Sema3F co-receptor, i.e., plexin-A4, showed
that plexin-A4 was detected in neurons and fibers throughout
the brain and spinal cord, including the neocortex, hippocam-
pus, lateral hypothalamus, red nucleus, facial nucleus, and the
mesencephalic trigeminal nucleus. Plexin-A4 antibodies labeled
fibers in the lateral septum, nucleus accumbens, several thala-
mic nuclei, SN pars reticulata, zona incerta, and pontine reticular
region, as well as in several cranial nerve nuclei (Gutekunst et al.,
2010).
Guidance molecules from the Slit/Robo family are also widely
expressed in the adult brain, as reported by Marillat et al. (2002).
For example, Robo1 and Robo2 are expressed in the caudate puta-
men, nucleus accumbens, thalamus, hypothalamus and SN, and
Robo1 is exclusively expressed in the VTA. Slit-1 is expressed in
the caudate putamen and the VTA, while Slit-1 and Slit-2 are
expressed in the thalamus and the hypothalamus, as well as in the
SN (Marillat et al., 2002).
Finally, Shh andWnts are also present in the adult brain, where
Shh receptors are expressed in a few areas, such as the hippocam-
pus and the superior colliculus (Charytoniuk et al., 2002). The
Wnt signaling pathway seems to be involved in adult neurogenesis
(Malaterre et al., 2007).
IN THE LESIONED ADULT BRAIN
After a lesion, the expression of ephrins, semaphorins, netrins,
and Slits is modulated at the lesioned site in the adult brain, and
has been shown to prevent an endogenous regeneration in most
cases. Indeed, ephrin-B2-EphB2 and EphA4 participate in the for-
mation of the glial scar after spinal cord injury (Bundesen et al.,
2003; Fabes et al., 2006) and prevent the regeneration of cor-
ticospinal tract axons, whereas EphA4 blockers promote axonal
regeneration and functional recovery after spinal cord lesion in
mice (Goldshmit et al., 2011). Moreover, the upregulation of
EphA4 in astrocytes seems to mediate astrocytic gliosis after cor-
tical lesion in the Marmoset Monkey (Goldshmit and Bourne,
2010). Ephrin-B1 expression is also upregulated in reactive astro-
cytes present in the denervated hippocampal region, whereas Eph
receptors are expressed in sprouting axons (Wang et al., 2005).
Long-range cues, such as Sema3A, may also prevent the regen-
eration of lesioned axons through a chemorepulsive signal result-
ing from its interaction in scar tissue with Npn-1 expressed in
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regenerating olfactory axons (Pasterkamp et al., 1998). In the
mouse spinal cord and cerebellum, netrin-1, Slit-1, and Slit-3 are
expressed at the lesion site in macrophages and fibroblasts, where
they may contribute to the regenerative failure of axons in the
adult CNS, by inhibiting axon outgrowth or by participating in
the formation of the CNS scar (Wehrle et al., 2005).
Lesioning of the mesotelencephalic pathway using 6-
hydroxydopamine injections in the striatum results in an increase
of Sema3A expression in striatal astrocytes one week after the
injection (Yasuhara et al., 2004). Thus, Sema3A could play a role
in the induction of cell death in dopaminergic neurons.
Overall, these repulsive molecular interactions after a lesion
may prevent an endogenous repair at the lesion site and, in some
cases, may contribute to the death of mDA neurons. However, a
repulsive activity may also be useful, if expressed outside of the
lesioned site, to maintain axons (either endogenously regenerated
axons or axons arising from grafted cells) on their pathway to
their final target. Then, it would be interesting to study whether
the chemical lesioning of the mesotelencephalic pathways could
induce a modulation of the expression of axon guidance cues in
the adjacent regions.
IN THE GRAFTED ADULT BRAIN
Several studies have investigated the potential of cell therapy in
animal models of PD. All these models are based on the induction
of chemical lesions of the nigrostriatal dopaminergic pathway
by injecting a toxin either into the SN or the striatum, or more
rarely into the MFB. The grafted cells could be rodent or human
embryonic stem (ES) cell-derived dopaminergic neurons, rodent
or human mesencephalic fetal cells or induced pluripotent stem
(iPS) cells (for review, see Gaillard and Jaber, 2011).
Zhou and Chiang (1995) first described a trophic effect of
excitochemicals injected after a lesion of the MFB, serving as
effective axonal guidance for fetal neurons to innervate distal
brain regions. Moreover, embryonic nigral transplants implanted
in the striatum are capable of promoting growth and provid-
ing guidance to axons arising from a dopaminergic graft placed
homotopically in the VM, resulting in dopaminergic nigrostri-
atal reinnervation (Mendez et al., 1996). Double grafts in the
striatum and SN can also reconnect the striato-nigro-striatal cir-
cuitry (Mendez and Hong, 1997). Grafted cell lines, such as the
human teratocarcinoma cell line (Baker and Mendez, 2005), also
allow for a reconstruction of the dopamine-denervated nigros-
triatal pathway. In 2001, the study of the therapeutic potential
of grafted cells crossed an important step with the generation
of transgenic mice expressing green fluorescent protein (GFP)
under the control of the rat TH gene promoter. GFP cells iso-
lated using fluorescence-activated cell sorting were transplanted
into a rat model of PD. Surviving cells innervated the host stria-
tum, resulting in a recovery of Parkinsonian behavioral defects
(Sawamoto et al., 2001). This strategy is very interesting, because
it allows grafted cells expressing GFP to be visualized in the
host brain. These advances lead to the publication of a series of
studies describing the reconstruction of the nigrostriatal path-
way after transplantation. Indeed, fetal dopaminergic neurons
implanted into the SN of adult mice are capable of substan-
tially reconnecting the nigrostriatal pathway with an outgrowth
pattern that matches the anatomy of the endogenous system
(Gaillard et al., 2009; Thompson et al., 2009). More precisely,
Thompson et al. (2005) showed that, in VM grafts, the dopamin-
ergic innervation of the striatum is derived almost exclusively
from Girk2-positive SN cells, whereas calbindin-positive VTA
neurons project to the frontal cortex and probably also other
forebrain areas. Furthermore, the A9 component of intrastriatal
grafts is critical for recovery, as shown through tests of motor per-
formance in a rodent model of PD (Grealish et al., 2010). This
suggests that specific guidance cues exist in the host brain that
can differentially guide the mDA axon subpopulations to their
respective, appropriate targets. Moreover, grafted cells seem to be
able to respond to these environmental cues. Indeed, rodent mes-
encephalic fetal cells are known to express receptors to guidance
cues, such as neuropilins (Hernandez-Montiel et al., 2008; Kolk
et al., 2009; Yamauchi et al., 2009), plexins (Torre et al., 2010), cell
adhesion molecules (Torre et al., 2010), DCC (Lin et al., 2005),
Robos (Marillat et al., 2002; Lin et al., 2005), and PCP recep-
tors (Fenstermaker et al., 2010; Blakely et al., 2011) (see details
in the first part of this review). However, whether the expres-
sion of specific guidance cues is modulated in the host brain after
transplantation remains to be determined.
In spite of their therapeutic potential, the use of fetal cells is
not without significant technical, ethical, political, and logisti-
cal issues that limit their generalized used in cell therapies. ES
cell-derived dopaminergic neurons are more widely available and
provide a great hope for cell replacement therapy in PD (Kriks
et al., 2011). Like fetal dopaminergic neurons, these cells express
the netrin receptor DCC and the Slit receptor Robo. Slit-2 repels
fetal dopaminergic neurites (Lin et al., 2005), as well asmouse and
human ES-derived DA axons (Lin and Isacson, 2006; Cord et al.,
2010). However, while netrin-1, Slit-1, and Slit-3 molecules can
guide fetal dopaminergic axons (Lin et al., 2005; Lin and Isacson,
2006), no directed neurite outgrowth was observed in the co-
cultures of ES cell-derived dopaminergic neurons with netrin-1,
Slit-1, and Slit-3-producing cells (Lin and Isacson, 2006). These
findings suggest that ES cell-derived dopaminergic neurons gen-
erated by current protocols can respond to guidance cues in vitro
in a similar manner to fetal cells. They also indicate that these
cells exhibit distinct responses that could be explained by devel-
opmental differences generated by current in vitro methods of
cell patterning or conditioning during ES cell differentiation (Lin
and Isacson, 2006). Moreover, human ES-derived dopaminer-
gic neurons attain peak responsiveness to these cues over time
in culture, confirming that the timing of dopaminergic trans-
plant is an important variable for future studies using human
ES-derived neurons in therapy. Other studies (Tamariz et al.,
2010) also showed that similar proportions of ES cell-derived
dopaminergic neurons and fetal cells from embryonic VM express
the semaphorin receptors Npn-1 and Npn-2. Furthermore, the
axons of both populations respond very similarly to semaphorin
exposure. Indeed, Sema3A increases axon length, and Sema3C
attracts axons and increases their length. These effects are medi-
ated by neuropilins, since the addition of blocking antibodies
against these proteins reduced the effects on axonal growth
and attraction. The phenotypic similarities between ES cell-
derived dopaminergic neurons and dopaminergic neurons from
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embryonic VM suggest that Sema3A and Sema3C may be used
to guide axons of grafted ES cell-derived dopaminergic neurons
in therapeutic protocols for PD (Tamariz et al., 2010). Sema3A
and Sema3C could be delivered at the target site to attract cell-
transplanted axons using a viral vector-mediated strategy, as used
for the expression of neurturin in the striatum of nonhuman
primates (Herzog et al., 2009), and more commonly, for neu-
rotrophic factors (for review Rangasamy et al., 2010). However,
as early stages of PD in humans leave a significant proportion of
the nigrostriatal projections intact, which may serve as a substrate
for regeneration and functional recovery (Bjorklund et al., 1997),
it is crucial to consider the possible duality of action of exoge-
nous guidance molecules on these regenerating axons and on the
transplanted-cell axons. Indeed, axonal growth and sprouting of
fibers in the CNS is partially inhibited by guidance molecules,
such as canonical axon guidance molecules (e.g., semaphorins,
ephrins, netrins), prototypic myelin inhibitors (Nogo, MAG, and
OMgp), and chondroitin sulfate proteoglycans (lecticans, NG2)
(Giger et al., 2010). Sema3A is more particularly known to inhibit
the regeneration of CNS axons (Pasterkamp and Giger, 2009),
although whereas it has a positive, attractive effect on embry-
onic and ES-derived dopaminergic neurons, as described above
(Tamariz et al., 2010).
Apart from acting on the expression of guidance cues local-
ized in the environment of the pathway, another way to improve
the transplantation efficacy could be to modulate the expression
of single or combined guidance cue receptors in the cells to be
transplanted. Enhancing or repressing their response to environ-
mental cues may be achieved using gene therapy, as it has been
previously done to replace enzymes involved in the dopamine
metabolism (for review, see Bjorklund et al., 2010). However,
modifying the expression of guidance molecule receptors before
transplantation would induce a modification of the axon guid-
ance all along the nigrostriatal pathway, from the initial site of
transplantation to the target site. This is an important issue,
because environmental cues do not direct the mDA axons in the
same manner all along their growth to the striatum. For example,
mesoprefrontal dopaminergic axons change their responsiveness
to Sema3F through the Npn-2 receptor, from repulsion to attrac-
tion through their course to the cortex (Kolk et al., 2009).
Ultimately, stem cell-derived dopaminergic neurons should
become more widely available, in large part thanks to recent tech-
nological advances that could allow for dopaminergic neurons
to be obtained from somatic cells of patients. Indeed, Wernig
et al. (2008) provided data suggesting recovery in rat models of
PD using iPS cells. Thus, because of their plasticity and ability
to undergo directed differentiation, iPS cells are promising can-
didates to replace dopaminergic cells and integrate themselves
synaptically into the recipient brain, thus providing a possible
alternative for the treatment of PD (Chen et al., 2011). The
expression of guidance cue receptors in iPS cells and the func-
tional effects of the molecular environment on axon guidance
remain to be determined. Indeed, the response to the known
embryonic dopaminergic axon guidance systems of the cells to be
transplanted in vitro, as well as after grafting, must be analyzed.
This is of paramount importance for the development of efficient
cell replacement strategies in PD, even if a partial restoration of
dopamine levels is sufficient to restore function in PD models
(Gaillard et al., 2009).
IN PARKINSONIAN PATIENTS
As early as 1997, experimental studies inferred that a genetic vari-
ability in the mDA axon guidance systems could contribute to
PD (Livesey and Hunt, 1997). Indeed, gene polymorphisms in the
mDA axon guidance system could result in an aberrant trajectory
of the ascending dopaminergic pathway during embryonic brain
development, and could then cause a congenital deficiency in
nigrostriatal dopamine. These developmental anatomic asymme-
tries in nigrostriatal innervation could account for motor asym-
metries later seen in patients (Djaldetti et al., 2006). Moreover,
individuals with these polymorphisms could be at greater risk
for PD and at an earlier age (Lesnick et al., 2007), as previously
described in patients with Tourette’s syndrome, which is associ-
ated with a rare sequence variation in a single axonal-dendritic
development gene (Abelson et al., 2005).
Several polymorphisms have been described in genes coding
for axon guidance cues. For instance, the Semaphorin5A gene
(SEMA5A) was shown to contain the single nucleotide polymor-
phism (SNP) most significantly associated with PD susceptibility
(Maraganore et al., 2005). Although Li et al. (2008) challenged
the robustness of the panel of genetic markers used to predict
PD risk and the mDA axon guidance system implication in PD
genetics, other SNPs have been recently reported as possible sus-
ceptibility factors for PD (Kim et al., 2011). Indeed, SNPs in
the DCC, calcium binding protein P22 (CHP), and related RAS
viral (r-ras) oncogene homolog 2 (RRAS2) and EPHB1 genes of
the mDA axon guidance system were significantly associated with
PD. The DCC rs17468382 and EPHB1 rs2030737 SNPs seem to be
associated with an increased risk of PD, and the CHP rs6492998
and RRAS2 rs2970332 SNPs seem to be associated with a reduced
risk of PD. Other genetic alterations in Parkinsonian patients
may also indirectly induce alterations in axon guidance. Indeed,
the LRRK2 protein, encoded by the PARK8 gene, is associated
with members of the Disheveled (DVL) family of phosphopro-
teins, involved in axon guidance and synapse formation. Thus,
the PARK8 mutation described in some Parkinsonian patients
may indirectly trigger axon guidance failure (Sancho et al., 2009).
Finally, it is important to consider that axon-guidance pathway
molecules could also contribute to the pathogenesis of PD via
their roles in axonal repair and in apoptotic signaling. Thus, poly-
morphisms within the pathway may render neurons more or less
vulnerable to endogenous or exogenous toxins that trigger cell
death (Shirvan et al., 2000; Yasuhara et al., 2004).
The transcriptional alteration of multiple genes involved in
axon guidance has also been described. Using microarrays,
Bossers et al. (2009) observed an upregulation by 197% of
the repulsive guidance protein RGMA in the SN and caudate
putamen of Parkinsonian patients, while the transcript levels
of ROBO2 were significantly reduced. In addition, the expres-
sion of neuropilin and tolloid (TLL)-like 2 (NETO2) and SLIT
and NTRK-like family, member 5 (SLITRK5) that were both
decreased in the SN of PD patients. In addition, syndecan 2
(SDC2), a heparan sulfate proteoglycan possibly involved in
regulating the function of some axon guidance molecules, was
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down-regulated in the PD SN. This decreased expression might
suggest a shift to a more repulsive nature of the extracellu-
lar matrix through a repulsive interaction of SEMA5A with
chondroitin sulfate proteoglycans. Indeed, when SEMA5A binds
to the heparan sulfate proteoglycan SDC3, it acts as an axon
attractant, and when it binds to chondroitin sulfate proteogly-
cans, it becomes a chemorepulsive protein (Kantor et al., 2004).
Altogether, the transcriptional alterations affecting multiple genes
involved in axon guidance and neurite outgrowth suggest an
altered and possibly more chemorepulsive environment around
mDA neurons. Changes in chemorepulsive signaling might con-
tribute to the loss of synaptic contacts between mDA neurons,
ultimately leading to a loss in these neurons. Elstner et al. (2009)
revealed an upregulation by 1.23 times of the Slit-Robo GTPase
activating protein 3 (srGAP3) in dopaminergic neurons of the
SNc of PD patients. These results support the importance of the
mDA axon guidance systems in the development of PD, because
srGAP3 is known to regulate the actin cytosqueleton downstream
of Slit-Robo signaling (Bashaw and Klein, 2010).
CONCLUDING REMARKS AND FUTURE DIRECTIONS
Ephrins, Slits, netrins, semaphorins, and Wnt proteins have been
described as the main families of axon guidance cues involved in
directing mDA axons during development. Most of them have a
repulsive effect on the mDA axons except Sema3F, which attracts
the mDA axons to the medial prefrontal cortex. It would be of
particular interest to investigate whether other attractive cues
could be responsible, for instance, for the formation of the tightly
fasciculated MFB or for the attraction of the mDA axon ter-
minals to the different tiers of the striatum. In any case, these
cells are able to respond to positive or negative environmen-
tal signals. Whether their response is sequential or simultaneous
to these signals remains to be determined, to better understand
how guidance cues can modulate their actions. Indeed, a simul-
taneous response to opposing signals would result in a push/pull
mechanism, defining the precise position of the axon terminals.
Another important point to consider is that mDA axon guid-
ance is often investigated as a homogenous pathway, although it
has been described to contain distinct subpopulations of axons
that could be differentially guided to their respective targets. It
is therefore of critical importance to refine the search for cel-
lular and molecular sources of guidance cues, considering the
heterogeneity mDA cell population. This is crucial if the aim is
to use these neurons in cell therapy to repair the mDA circuitry
in patients with PD. Finally, it appears essential to identify the
molecular and cellular environment of grafted cells after trans-
plantation and to determine how these cells are interacting with
this molecular environment. This may help to understand how
these pathways are anatomically and functionally reconstructed
in animal models of PD, and in turn, may improve the efficiency
of cell therapy in PD patients.
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